Pipeline Overview
Our expanding development program currently includes four repurposed drugs, in different phases of development.
Code | Indication | Drug Status | Human Efficacy | Patent Protection | Regulatory Pathway |
---|---|---|---|---|---|
OP001 | Opioid Addiction | Reformulated generic | Yes | Pending | 505(B)(2) |
OP002 | Pain Reduction Alternative in Opioid Users | Reformulated generic | Yes | Pending | 505(B)(2) |
OP003 | Prevention of Opioid Induced Respiratory Depression | Reformulated generics combination | Yes | Pending | 505(B)(2) |
OP004 | Enhanced Effect Lower Dose Opioids for Pain Relief | Reformulated generics combination | Yes | Pending | 505(B)(2) |